SurModics/$SRDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About SurModics
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Ticker
$SRDX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
389
ISIN
US8688731004
Website
SurModics Metrics
BasicAdvanced
$426M
-
-$1.40
1.30
-
Price and volume
Market cap
$426M
Beta
1.3
52-week high
$42.44
52-week low
$26.00
Average daily volume
74K
Financial strength
Current ratio
5.143
Quick ratio
3.759
Long term debt to equity
28.819
Total debt to equity
29.759
Interest coverage (TTM)
-1.14%
Management effectiveness
Return on assets (TTM)
-1.44%
Return on equity (TTM)
-16.96%
Valuation
Price to revenue (TTM)
3.485
Price to book
3.87
Price to tangible book (TTM)
9.37
Price to free cash flow (TTM)
-56.929
Growth
Revenue change (TTM)
-14.96%
Earnings per share change (TTM)
-246.55%
3-year revenue growth (CAGR)
7.84%
3-year earnings per share growth (CAGR)
22.50%
What the Analysts think about SurModics
Analyst ratings (Buy, Hold, Sell) for SurModics stock.
SurModics Financial Performance
Revenues and expenses
SurModics Earnings Performance
Company profitability
SurModics News
AllArticlesVideos
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
Business Wire·1 month ago
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
Business Wire·1 month ago
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SurModics stock?
SurModics (SRDX) has a market cap of $426M as of June 06, 2025.
What is the P/E ratio for SurModics stock?
The price to earnings (P/E) ratio for SurModics (SRDX) stock is 0 as of June 06, 2025.
Does SurModics stock pay dividends?
No, SurModics (SRDX) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next SurModics dividend payment date?
SurModics (SRDX) stock does not pay dividends to its shareholders.
What is the beta indicator for SurModics?
SurModics (SRDX) has a beta rating of 1.3. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.